Phio Pharmaceuticals Files 8-K
Ticker: PHIO · Form: 8-K · Filed: Jun 26, 2025 · CIK: 1533040
| Field | Detail |
|---|---|
| Company | Phio Pharmaceuticals Corp. (PHIO) |
| Form Type | 8-K |
| Filed Date | Jun 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-event, filing
TL;DR
Phio Pharma dropped an 8-K, check it for deets.
AI Summary
Phio Pharmaceuticals Corp. filed an 8-K on June 26, 2025, reporting on events as of June 25, 2025. The filing is categorized under 'Other Events' and 'Financial Statements and Exhibits'. The company, formerly known as RXi Pharmaceuticals Corp., is incorporated in Delaware and headquartered in Marlborough, Massachusetts.
Why It Matters
This 8-K filing indicates significant corporate events or financial updates for Phio Pharmaceuticals Corp., requiring investor attention.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting events and does not inherently signal high risk.
Key Numbers
- 001-36304 — SEC File Number (Identifier for the company's filings)
- 45-3215903 — EIN (Employer Identification Number)
Key Players & Entities
- Phio Pharmaceuticals Corp. (company) — Registrant
- RXi Pharmaceuticals Corp. (company) — Former company name
- June 25, 2025 (date) — Date of earliest event reported
- June 26, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Marlborough, Massachusetts (location) — Principal executive offices
FAQ
What specific 'Other Events' are being reported by Phio Pharmaceuticals Corp. in this 8-K?
The filing indicates 'Other Events' as an item, but the specific details of these events are not provided in the provided text snippet.
What is the significance of the 'Financial Statements and Exhibits' being listed?
This suggests that the 8-K filing includes or references financial statements and other exhibits, which could contain important financial information or supporting documents.
When was Phio Pharmaceuticals Corp. formerly known as RXi Pharmaceuticals Corp. and when did the name change occur?
The filing states the former company name was RXi Pharmaceuticals Corp. and the date of name change was October 19, 2011.
What is the principal executive office address for Phio Pharmaceuticals Corp.?
The principal executive offices are located at 11 Apex Drive, Suite 300A, PMB 2006, Marlborough, Massachusetts 01752.
What is the filing date and the date of the earliest event reported in this 8-K?
The filing date is June 26, 2025, and the date of the earliest event reported is June 25, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 26, 2025 regarding Phio Pharmaceuticals Corp. (PHIO).